Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Guidelines for the Clinical Management of HIV/AIDS - Tanzania (NACP; 2005; 131 pages)
View the documentLIST OF ABBREVIATIONS
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
Open this folder and view contentsCHAPTER 1: INTRODUCTION
Open this folder and view contentsCHAPTER 2: ORGANIZATION OF HIV/AIDS CARE AND TREATMENT
Open this folder and view contentsCHAPTER 3: HIV/AIDS PREVENTION
Open this folder and view contentsCHAPTER 4: PROTECTIVE MEASURES AGAINST HIV TRANSMISSION
Open this folder and view contentsCHAPTER 5: LABORATORY TESTS IN HIV/AIDS
close this folderCHAPTER 6: HIV/AIDS AND PREGNANCY
View the document6.1 Introduction
View the document6.2 Mother to Child Transmission of HIV (MTCT)
View the document6.3 Prevention of Mother to Child Transmission of HIV (PMTCT)
close this folder6.4 Antenatal care of women with HIV/AIDS
View the document6.4.1 Care during labour and delivery
View the document6.4.2 Postnatal care of a woman with HIV/AIDS
View the document6.4.3 Follow up for the HIV Exposed Child
View the document6.4.4 Use of prophylactic antiretroviral (ARV) drugs during pregnancy
Open this folder and view contentsCHAPTER 7: PEDIATRIC HIV/AIDS AND RELATED CONDITIONS
Open this folder and view contentsCHAPTER 8: COMMUNITY AND HOME BASED CARE FOR PEOPLE LIVING WITH HIV/AIDS (PLHA)
Open this folder and view contentsCHAPTER 9: COUNSELLING RELATED TO HIV-TESTING AND TREATMENT ADHERENCE
Open this folder and view contentsCHAPTER 10: MANAGEMENT OF COMMON SYMPTOMS AND OPPORTUNISTIC INFECTIONS IN HIV/AIDS
Open this folder and view contentsCHAPTER 11: MANAGEMENT OF MENTAL HEALTH PROBLEMS IN HIV/AIDS
Open this folder and view contentsCHAPTER 12: MANAGEMENT OF HIV INFECTED PATIENTS USING ANTIRETROVIRAL DRUGS
Open this folder and view contentsCHAPTER 13: ARV THERAPY IN INFANTS AND CHILDREN
Open this folder and view contentsCHAPTER 14: USE OF ARVS IN SPECIAL CIRCUMSTANCES
Open this folder and view contentsCHAPTER 15: HIV/AIDS AND NUTRITION
Open this folder and view contentsCHAPTER 16: MANAGEMENT OF ANTIRETROVIRAL MEDICINES
Open this folder and view contentsCHAPTER 17: CERTIFICATION OF HEALTHCARE FACILITIES AS CARE AND TREATMENT SITES
 

6.4.3 Follow up for the HIV Exposed Child

Babies born in health care facilities should receive an MCH card in which NVP prophylaxis dose must be indicated if given.

Routine follow up (up to one year - monthly; then up to 5 years, 3 monthly)

Do a full clinical re-assessment at each follow up visit including growth and developmental assessment

Counsel about feeding practices. Avoid giving both breast milk and formula milk (mixed feeding) in the first 6 months of life

Start Cotrimoxazole prophylaxis from 6 weeks onwards. (For dosages see table 6.2)

Perform an antibody test for HIV infection at 18 months, and if child is breastfeeding, at 6 weeks after stopping breastfeeding. If PCR test is available it should not be done before 6 weeks. If the initial PCR is positive, a repeat test is recommended before disclosure of results.

to previous sectionto next section

Please provide your feedback English  |  French